Syntrophin and dystrobrevin (SNTA/DTNA)

Syntrophins and dystrobrevins are essential cytoplasmic components of the Dystrophin-Associated Glycoprotein Complex (DAGC), serving as a critical link between the intracellular cytoskeleton and the extracellular matrix [1]. Syntrophins (alpha, beta, gamma isoforms) function as modular adapter proteins, utilizing their PDZ domains to recruit signaling molecules such as neuronal nitric oxide synthase (nNOS), aquaporin-4 (AQP4), and various ion channels to the sarcolemma [2]. Dystrobrevins (alpha and beta) are dystrophin-related proteins that contribute to the structural stability of the DAGC and play roles in cell signaling and the maturation of the neuromuscular junction [3]. Deficiencies or mislocalization of these proteins are implicated in the pathogenesis of Duchenne and Becker muscular dystrophies, as well as certain forms of cardiomyopathy and Long QT syndrome [4]. While they are not typically the direct targets of small-molecule inhibitors, they are the functional targets of regenerative and genetic therapies, such as exon-skipping oligonucleotides (e.g., Eteplirsen) and gene therapies (e.g., Delandistrogene moxeparvovec), which aim to restore the entire DAGC to the muscle membrane [5]. Maintaining the integrity of the syntrophin-dystrobrevin subcomplex is vital for preventing muscle fiber necrosis and ensuring proper nitric oxide-mediated vasodilation during exercise [6].

Other names

Syntrophin-dystrobrevin complexDystrophin-associated proteinsSNTDTNDystrophin-associated glycoprotein complex subcomplex

Restoration and stabilization of the Dystrophin-Associated Glycoprotein Complex (DAGC) at the sarcolemma to maintain structural integrity and signaling.